CS logo
small CS logo
Arthritis and Rheumatology of Georgia

Atlanta, Georgia, United States
Rheumatologist in Sandy Springs, Georgia
980 Johnson Ferry Rd NE #220, Atlanta, GA 30342

About Arthritis and Rheumatology of Georgia


  • Top Sponsors
  • Top Collaborators
  • Trials By Phase
  • Recruitment Status
  • Top Conditions
  • Intervention Types
  • Top Intervention Names
  • Trials By Gender
Lead Sponsor
# Trials
Pfizer
4
Amgen
3
Hoffmann-La Roche
3
Bristol-Myers Squibb
2
Eli Lilly and Company
1
Kiniksa Pharmaceuticals (UK), Ltd.
1
Mallinckrodt
1
Pfizer's Upjohn has merged with Mylan to form Viatris Inc.
1
Total Rows: 8

Clinical Trials at Arthritis and Rheumatology of Georgia


During the past decade, Arthritis and Rheumatology of Georgia conducted 4 clinical trials. In the 10-year time frame, 4 clinical trials started and 9 clinical trials were completed, i.e. on average, 225% percent of trials that started reached the finish line to date. In the past 5 years, 1 clinical trials started and 5 clinical trials were completed. i.e. 500% of trials that started reached the finish line.
Created with Highcharts 11.1.0TrialsTrials Trend - Last 10 Years110000220011002211111144Started TrialsCompleted Trails2016201720182019202020210246
Trials List
Trail ID
Brief Title
Start Date
Completion Date
Status
Enrollment
Prospective Randomized Evaluation Of Celecoxib Integrated Safety Vs Ibuprofen Or Naproxen
2006-10-04
2016-04-12
Completed
24,081
A Study of the Effect of Tocilizumab on Markers of Atherogenic Risk in Patients With Moderate to Severe Rheumatoid Arthritis
2007-10-31
2011-01-31
Completed
132
Methotrexate-Inadequate Response Study
2008-01-01
2014-09-01
Completed
2,492
Tanezumab in Osteoarthritis Of The Hip
2008-11-17
2010-08-13
Completed
627
Extension Study Of Tanezumab In Osteoarthritis
2009-02-06
2011-06-23
Terminated
2,147
Tanezumab In Osteoarthritis Of The Knee (2)
2009-05-05
2010-08-31
Completed
832
Abatacept Versus Adalimumab Head-to-Head
2009-10-01
2012-11-01
Completed
869
PF-00489791 For The Treatment Of Raynaud's
2010-08-04
2011-05-31
Completed
243

Rows per page:

1–16 of 16

Clinical Trials Sponsors and Collaborators


Out of the total clinical trials conducted in "Arthritis and Rheumatology of Georgia" #1 sponsor was "Pfizer" with 4 trials, followed by "Amgen" with 3 trials sponsored, "Hoffmann-La Roche" with 3 trials sponsored, "Bristol-Myers Squibb" with 2 trials sponsored and "Eli Lilly and Company" with 2 trials sponsored. Other sponsors include -2 different institutions and companies that sponsored additional 8 trials in total.
In terms of collaborators to trials, out of the total clinical trials conducted in "Arthritis and Rheumatology of Georgia" #1 collaborator was "Incyte Corporation" with 1 trials as a collaborator and "The Cleveland Clinic" with 1 trials as a collaborator. Other collaborators include -2 different institutions and companies that were collaborators in the rest 2 trials.
Created with Highcharts 11.1.0Top Leading SponsorsPfizer: 4Pfizer: 4Amgen: 3Amgen: 3Hoffmann-La Roche: 3Hoffmann-La Roche: 3Bristol-Myers Squibb: 2Bristol-Myers Squibb: 2Eli Lilly and Company: 1Eli Lilly and Company: 1Kiniksa Pharmaceuticals(UK), Ltd.: 1Kiniksa Pharmaceuticals(UK), Ltd.: 1Mallinckrodt: 1Mallinckrodt: 1Pfizer's Upjohn hasmerged with Mylan toform Viatris Inc.: 1Pfizer's Upjohn hasmerged with Mylan toform Viatris Inc.: 1

Created with Highcharts 11.1.0Top CollaboratorsIncyte Corporation: 1Incyte Corporation: 1The Cleveland Clinic: 1The Cleveland Clinic: 1

Clinical Trials Conditions at Arthritis and Rheumatology of Georgia


According to Clinical.Site data, the most researched conditions in "Arthritis and Rheumatology of Georgia" are "Rheumatoid Arthritis" (4 trials), "Osteoarthritis" (3 trials), "Arthritis" (2 trials), "Arthritis, Rheumatoid" (2 trials) and "Psoriatic Arthritis" (2 trials). Many other conditions were trialed in "Arthritis and Rheumatology of Georgia" in a lesser frequency.

Clinical Trials Intervention Types at Arthritis and Rheumatology of Georgia


Most popular intervention types in "Arthritis and Rheumatology of Georgia" are "Drug" (14 trials), "Biological" (3 trials) and "Other" (1 trials). Other intervention types were less common.
The name of intervention was led by "Placebo" (7 trials), "Apremilast 20mg" (2 trials), "Apremilast 30mg" (2 trials), "Tocilizumab" (2 trials) and "tanezumab" (2 trials). Other intervention names were less common.

Clinical Trials Genders at Arthritis and Rheumatology of Georgia


The vast majority of trials in "Arthritis and Rheumatology of Georgia" are 16 trials for "All" genders.

Clinical Trials Status at Arthritis and Rheumatology of Georgia


Currently, there are NaN active trials in "Arthritis and Rheumatology of Georgia". undefined are not yet recruiting, 1 are recruiting, 1 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 13 completed trials in Arthritis and Rheumatology of Georgia, undefined suspended trials, and 1 terminated clinical trials to date.
Out of the total trials that were conducted in Arthritis and Rheumatology of Georgia, 0 "Phase 1" clinical trials were conducted, 1 "Phase 2" clinical trials and 11 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 4 trials, and there were also 0 trials that are defined as “Not Applicable".
Created with Highcharts 11.1.0Trials By PhasePhase 3: 11Phase 3: 11Phase 4: 4Phase 4: 4Phase 2: 1Phase 2: 1

Created with Highcharts 11.1.0Trials StatusCompleted: 13Completed: 13Active, not recruiting: 1Active, not recruiting: 1Recruiting: 1Recruiting: 1Terminated: 1Terminated: 1